You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 10,507,132


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,507,132 protect, and when does it expire?

Patent 10,507,132 protects MIEBO and is included in one NDA.

This patent has sixteen patent family members in eleven countries.

Summary for Patent: 10,507,132
Title:Topical administration method
Abstract:The present invention relates to a method for topical administration of ophthalmic compositions in a dropwise manner, preferably for topical administration of ophthalmic compositions comprising semifluorinated alkanes (SFAs). Further, the present invention relates to the use of said methods in the prevention or treatment of ocular diseases or disorders or any symptoms or conditions associated therewith. In a further aspect, the present invention relates to a kit comprising a drop dispenser at least partially filled with a liquid composition for the use in such a method and directions for use of said drop dispenser.
Inventor(s):Graf Gesche, Ahmed Yasin, Legner Stephanie, Kemp Philip
Assignee:NOVALIQ GMBH
Application Number:US16312855
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

United States Patent 10,507,132: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 10,507,132, titled "Topical administration method," is a patent that outlines a method for the topical administration of ophthalmic compositions. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Publication Details

  • Publication Number: US10507132B2
  • Filing Date: Related to application US16/312,855
  • Prior Art Date: Relevant dates indicate the timeline of the invention's development and its precedence over other similar inventions[4].

Invention Description

The patent describes a method for the topical administration of ophthalmic compositions, specifically in a dropwise manner. This method is designed for the efficient and precise delivery of ophthalmic drugs, addressing issues such as dry eye syndromes and other ocular disorders[4].

Scope of the Patent

Technical Scope

The patent focuses on the technical aspects of delivering ophthalmic compositions. It includes details on the use of a dropper, the composition of the liquid, and the design of the bottle to ensure accurate and consistent drop sizes. The scope is narrow, targeting a specific application within ophthalmology[4].

Market Scope

The market scope involves the treatment of various ocular conditions, including dry eye syndromes, which are common and affect a significant population. The method described could be a valuable addition to existing treatments, potentially improving patient outcomes and quality of life[4].

Claims of the Patent

Independent Claims

The patent includes several independent claims that define the core aspects of the invention. These claims typically cover the method of administration, the composition of the ophthalmic solution, and the apparatus used for delivery. For example, Claim 1 might describe the method of administering the composition in a dropwise manner using a specific type of dropper[4].

Dependent Claims

Dependent claims build upon the independent claims, providing additional details or variations of the invention. These could include specific concentrations of active ingredients, the material of the dropper, or additional steps in the administration process. These claims help to further define the scope of the invention and protect against potential infringements[4].

Patent Landscape

Prior Art

The patent landscape includes an analysis of prior art, which involves examining existing patents and publications related to ophthalmic drug delivery. The Common Citation Document (CCD) application, for instance, consolidates prior art cited by multiple patent offices, helping to identify relevant prior art quickly[1].

Competing Patents

Other patents in the field of ophthalmic drug delivery are relevant to understanding the competitive landscape. For example, patents related to drug delivery vehicles, such as those involving micronized particles, could be seen as competitors or complementary technologies[5].

International Patent Offices

The global patent landscape is crucial, as similar inventions may have been patented in other countries. Databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) are essential for a comprehensive search[1].

Search Resources

USPTO Resources

The United States Patent and Trademark Office (USPTO) offers several resources for searching patents, including the Patent Public Search tool, Global Dossier, and the Public Search Facility. These resources are invaluable for conducting thorough searches and understanding the patent landscape[1].

International Databases

Access to international patent databases, such as esp@cenet by the EPO and PATENTSCOPE by WIPO, is crucial for a global perspective. These databases provide machine translations and full-text searches, facilitating a more comprehensive analysis[1].

Economic and Legal Implications

Market Impact

The economic impact of this patent could be significant, especially if the method proves more effective or efficient than existing treatments. It could lead to increased market share for the patent holder and improved patient outcomes.

Legal Considerations

The legal status of the patent, including any office actions or litigation, is critical. The Patent Examination Data System (PEDS) and the Patent Assignment Search website can provide insights into the patent's legal history and current status[1].

Expert Insights

Industry Experts

Industry experts in ophthalmology and pharmaceuticals can provide valuable insights into the practical applications and potential impact of this patent. For instance, "The creation of the CCD application is part of an ongoing process of technical harmonization at the international level aimed at establishing an appropriate infrastructure to facilitate greater integration of the global patent system," highlights the importance of harmonization in patent searches[1].

Statistics and Trends

Patent Scope Measurements

Research datasets, such as the Patent Claims Research Dataset by the USPTO, provide detailed information on claims and patent scope. These datasets can help in understanding trends in patent scope and the impact of such patents on the industry[3].

Citation Data

The Common Citation Document (CCD) application consolidates citation data from multiple patent offices, providing a single point of access to prior art citations. This can help in identifying the relevance and impact of the patent within the broader patent landscape[1].

Key Takeaways

  • Specific Method: The patent describes a specific method for topical administration of ophthalmic compositions.
  • Technical and Market Scope: The scope is narrow technically but has significant market potential.
  • Claims Structure: Independent and dependent claims define the core and variations of the invention.
  • Prior Art and Competitors: A thorough search of prior art and competing patents is essential.
  • Global Perspective: International databases and resources are crucial for a comprehensive analysis.
  • Economic and Legal Implications: The patent could have significant economic and legal implications.

FAQs

Q: What is the main focus of United States Patent 10,507,132?

A: The main focus is a method for the topical administration of ophthalmic compositions in a dropwise manner.

Q: How can one search for similar patents internationally?

A: One can use databases such as esp@cenet by the EPO, PATENTSCOPE by WIPO, and other international patent offices' databases.

Q: What resources does the USPTO provide for patent searching?

A: The USPTO provides resources like the Patent Public Search tool, Global Dossier, Public Search Facility, and Patent and Trademark Resource Centers (PTRCs).

Q: How important is prior art in patent analysis?

A: Prior art is crucial as it helps in understanding the novelty and non-obviousness of the invention and in identifying potential competitors.

Q: Where can one find detailed information on patent claims and scope?

A: The Patent Claims Research Dataset by the USPTO and other research datasets provide detailed information on claims and patent scope.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. DrugPatentWatch - Patent 10,507,132: https://www.drugpatentwatch.com/p/patent/10507132
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Google Patents - US10507132B2: https://patents.google.com/patent/US10507132B2/en
  5. Unified Patents - WO-2022235252-A1: https://portal.unifiedpatents.com/patents/patent/WO-2022235252-A1

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,507,132

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch And Lomb Inc MIEBO perfluorohexyloctane SOLUTION/DROPS;OPHTHALMIC 216675-001 May 18, 2023 RX Yes Yes 10,507,132 ⤷  Subscribe TREATMENT OF THE SIGNS AND SYMPTOMS OF DRY EYE DISEASE (DED) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,507,132

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2017281296 ⤷  Subscribe
Canada 3027767 ⤷  Subscribe
China 109640900 ⤷  Subscribe
Denmark 3442480 ⤷  Subscribe
European Patent Office 3442480 ⤷  Subscribe
European Patent Office 3618782 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.